No abstract available
MeSH terms
-
Aged
-
Aged, 80 and over
-
Antibodies, Monoclonal* / therapeutic use
-
Carcinoma, Transitional Cell* / drug therapy
-
Carcinoma, Transitional Cell* / pathology
-
Female
-
Humans
-
Japan / epidemiology
-
Male
-
Middle Aged
-
Retrospective Studies
-
Treatment Outcome
-
Urinary Bladder Neoplasms* / drug therapy
-
Urinary Bladder Neoplasms* / pathology
Substances
-
Antibodies, Monoclonal
-
enfortumab vedotin